Abstract
Chrysosporium, a genus of ascomycete fungi in the family Onygenaceae, has the ability to produce abundant new bioactive natural products, providing a structural foundation in drug development. This review includes the sources, distribution, biological activities and structural characteristics of the compounds isolated from Chrysosporium from 1984 to 2021. The results show that 66% of the compounds isolated from Chrysosporium are new natural products. More than half of the Chrysosporium-isolated compounds are from marine-derived Chrysosporium. The chemical structures of Chrysosporium-derived compounds have different skeletons, which are concentrated in alkaloids, polyketides, and lactones. Eighty percent of the natural products isolated from Chrysosporium have been found to have various biological activities, including cytotoxic, antibacterial, antifungal and enzyme-inhibitory activities. These results demonstrate the potential of Chrysosporium for producing new bioactive secondary metabolites, which can be used as the structural basis for developing new drugs.
Funder
National Natural Science Foundation of China
Shandong Provincial Natural Science Foundation
Talent Support Program of Shandong University of Science and Technology
Subject
Plant Science,Biochemistry, Genetics and Molecular Biology (miscellaneous),Food Science
Reference59 articles.
1. Sturm, J. (1833). Deutschlands Flora 3, Nabu Press.
2. Taxonomic advance and characteristics of the genus Chrysosporium;Han;J. Mt. Agric. Biol.,2017
3. Saccardo, P.A. (1901). Sylloge Fungorum 15, Wentworth Press.
4. Revisiones hyphomycetum aliquot cum appendice de nominibus rejiciendis;Hughes;Can. J. Bot.,1958
5. A revision of Chrysosporium and allied genera;Stud. Mycol.,1980
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献